CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
6 research outputs found
Bioequivalence of recombinant human FSH and recombinant human LH in a fixed 2 : 1 combination: two phase I, randomised, crossover studies
Author
C. Rossier
De Placido G
+12Â more
Humaidan P
I. Lugan
le Contonnec JY
le Cotonnec JY
le Cotonnec JY
le Cotonnec JY
M. Picard
O. Papasouliotis
Porchet HC
Stokman PG
The European Recombinant Human LH Study Group
van de Weijer BH
Publication venue
'Informa Healthcare'
Publication date
Field of study
No full text
Crossref
15 De frameprothese in de maxillofaciale prothetiek
Author
A Shifman
B Conroy
+31Â more
D Rohner
DJ Okay
G Colella
GR Parr
J Beumer III
J Rieger
JS Brown
L Ramamurthy
M Marunick
M. Marunick
MA Stokman
MA. Aramany
MA. Aramany
MP Karnell
N Sahin
N Worsaae
ND Futran
NJ Jepson
PG Cordeiro
PJ Schoen
PK. Vallittu
RH Schepers
RL Schneider
RP. Desjardins
SJ Esposito
SJ Larsen
SM Cameron
T Kanno
TR. Talbot
WD Gay
Y Suzuki
Publication venue
'Springer Science and Business Media LLC'
Publication date
01/01/2012
Field of study
No full text
Crossref
Efficacy of Low-Dose Human Chorionic Gonadotropin (hCG) in a GnRH Antagonist Protocol
Author
A Golan
AJ Zeleznik
+36Â more
AP Ferraretti
C Alvano
CM Howles
CV Rao
E Loumaye
EM Kolibianakis
Garirelix ose Finding Study Group
H Al-Inary
J Tesaric
J Tesarik
JD Stanger
K Takahashi
Kumagai Shima
Kyono Koichi
M Filicori
M Filicori
M Filicori
M Filicori
M Filicori
M Ludwig
M Semesh
M Sullivan
Nakajo Yukiko
P Humaidan
PG Stokman
R Fanchin
R Fanchin
R Fleming
R Homburg
R Marrs
S Chappel
Sasaki Sachiko
SG Hillier
The European Recombinant Human LH Study Group
The European Recombinant LH study Group
UD Gordon
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Historischer Abriss zur Reproduktionsmedizin
Author
A Eshkol
A Huxley
+63Â more
A Laws-King
A Trounson
A Trounson
AC Steirteghem Van
AC Steirteghem Van
AH Handyside
AO Trounson
AO Trounson
AV Schally
B Aschner
B Lunenfeld
B Lunenfeld
B Zondek
B Zondek
B Zondek
C Chen
C Mazer
CA Gemzell
D Kretzer
D Molloy
E Knobil
E Knobil
E Ostergaard
E Ron
Editorial
G Bettendorf
G Palermo
G Pincus
GH Zeilmaker
HH Cole
HK Snick
IJ Duijkers
J Cummins
JI Cochius
JM Sims
K Groot-Wassink
L Wildt
LJ Dumble
M Army
M Wikland
P Donini
P Donini
P Lutjen
PC Steptoe
PC Steptoe
PC Steptoe
PE Smith
PE Smith
PG Stokman
PM Bouloux
R Agrawal
R Borth
R Guillemin
RB Greenblatt
RD Nachtigall
RG Edwards
RH Asch
RH Asch
RL Gardner
RN Porter
RS Finkler
SC Ng
SL Fevold
Publication venue
'Springer Science and Business Media LLC'
Publication date
01/01/2013
Field of study
No full text
Crossref
Is there a Need for Recombinant Human Luteinizing Hormone (Lutropin Alfa) Supplementation in Ovarian Stimulation for Assisted Reproduction?
Author
Adams J
Alviggi C
+67Â more
Balasch J
Balasch J
Balasch J
Balasch J
Balen AH
Behre HM
Cedrin-Durnerin I
Chappel SC
Daya S
Daya S
De Placido G
De Placido G
De Placido G
De Placido G
Drakakis P
Erickson GF
Erickson GF
Esposito MA
Fabregues F
Fanchin R
Ferraretti AP
Filicori M
Filicori M
Filicori M
Fleming R
Fleming R
Foong SC
Glueck CJ
Gougeon A
Greb RR
Griesinger G
Hillier SG
Hillier SG
Ho JYP
Howles CM
Howles CM
Howles CM
Hugues JN
Huhtaniemi IT
Hull M
Humaidan P
Humaidan P
Jiang M
Kolibianakis EM
Lisi F
Liu SY
Loumaye E
Marrs R
Mitchell R
Oktay K
Piltonen T
Robertson DM
Ropelato MG
Ryan KJ
Sauer MV
Shima K
Shoham Z
Sills ES
Stanger JD
Stokman PG
Tarlatzis B
Tesarik J
Tesarik J
The European Recombinant Human LH Study Group
Vihko KK
Westergaard LG
Westergaard LG
Publication venue
'Future Medicine Ltd'
Publication date
Field of study
No full text
Crossref
Treatment of female infertility with recombinant human luteinising hormone: is there a benefit over other available drugs?
Author
ABBASI R
ARMSTRONG DT
+76Â more
ARUFFO A
BAER G
BALASCH J
BALASCH J
BEHRMAN HR
BRAUNSTEIN GD
BROWN JB
CARGILLE CM
CARON MG
CHABBERT-BUFFET N
CHANNING CP
CHRISP P
COUZINET B
DAMEWOOD MD
DEMOULIN A
ESPOSITO MA
FEVOLD HL
FILICORI M
FILICORI M
FILICORI M
FLEMING R
FONG Y
FORMAN R
FRITZ MA
GIDLEY-BAIRD AA
GOLAN A
GREEN ED
HILLIER SG
HOFF JD
HOWLES CM
Human recombinant luteinising hormone is as effective as but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilisation procedures
IMTHURN B
ITSKOVITZ-ELDOR J
JULIUS D
KEUTMANN HT
KYLE CV
LAMPRECHT SA
LE COTONNEC JY
LE COTONNEC JY
LE COTONNEC JY
LISI F
LISI F
LOUMAYE E
LOUMAYE E
MARSH JM
MARSH JM
MENON KM
NADER S
NAYLOR SL
NOYES N
PAREKH RB
PELUSO JJ
PIERCE JG
PORCHET HC
PORTER RN
RABAU E
RANASINGHE L
RICHARDS JS
ROBINSON J
RYAN KJ
SCHOOT DC
SCHOOT DC
SEIBEL MM
SHERIZLY I
SHOHAM Z
SHOHAM Z
SHOHAM Z
SHOHAM Z
SHOHAM Z
SHORT RV
SILLS ES
STOKMAN PG
THE EUROPEAN RECOMBINANT HUMAN LH STUDY GROUP
ULLOA-AGUIRRE A
VANDE WIELE RL
WESTERGAARD LG
Publication venue
'Informa Healthcare'
Publication date
Field of study
No full text
Crossref